Phytonadione Tablet
FDA Label NDC 0904-6882

21 label sections · Submitted to the FDA by Major Pharmaceuticals · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Major Pharmaceuticals for the product Phytonadione (NDC 0904-6882). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1    dosing considerations, 2.2    recommended dosage, 3 dosage forms and strengths, 4 contraindications, 6 adverse reactions, 7 drug interactions, 8.1 pregnancy, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package/Label Display Panel

MAJOR®

NDC 0904-6882-10

Unit Dose

Phytonadione

Tablets, USP

5 mg

20 TABLETS (2 x 10)

Rx only

5mg Carton Label (94d89db9 981d 4fc5 B6fe 5d4b73230e35 00)

5mg Carton Label (94d89db9 981d 4fc5 B6fe 5d4b73230e35 00)

* Please review the disclaimer below.